SHBG Explained: What Sex Hormone-Binding Globulin Means for Your Testosterone

What Is SHBG and Where Does It Come From?

SHBG is a glycoprotein synthesized by liver hepatocytes. It travels through the bloodstream and binds to sex steroids, primarily testosterone and estradiol, with high affinity. Testosterone bound to SHBG cannot enter target cells, cannot activate androgen receptors, and produces no androgenic effect.

The liver regulates SHBG output in response to circulating hormones, metabolic signals, and inflammatory states. Insulin suppresses SHBG gene expression, which is why men with type 2 diabetes or obesity typically show low SHBG on labs. Thyroid hormones, by contrast, upregulate hepatic SHBG synthesis, so hyperthyroidism drives SHBG sharply higher [1].

A landmark study published in the Journal of Clinical Endocrinology and Metabolism confirmed that SHBG levels rise an average of 1.24% per year in aging men, compounding the total-testosterone decline that also occurs with age [2]. That means a 60-year-old man may carry substantially more SHBG than he did at 30, even if his total testosterone has not changed dramatically, leaving far less free hormone to act on muscle, bone, and brain.

Genetics also matter. Variants in the SHBG gene on chromosome 17p13 explain roughly 40 to 50% of the population variance in circulating SHBG concentrations [3]. Two men with identical total testosterone levels may have free testosterone values that differ by 50% or more simply because of inherited SHBG production rates.

Free Testosterone vs. Total Testosterone: Why the Distinction Matters Clinically

Total testosterone measures all testosterone in the blood: bound to SHBG, bound to albumin, and free. Free testosterone is the unbound fraction. The difference is not trivial.

Standard lab panels report total testosterone. That number includes hormone that is, for practical purposes, locked away. Men with high SHBG can register a total testosterone of 600 ng/dL and still experience fatigue, low libido, and loss of lean mass because their free testosterone sits below 50 pg/mL. The Endocrine Society's 2018 clinical practice guideline on testosterone therapy states: "We recommend measurement of free testosterone or bioavailable testosterone in men in whom total testosterone measurement may not accurately reflect androgen status, including men with altered SHBG concentrations" [4].

The calculation most labs use for free testosterone (the Vermeulen equation) depends on total testosterone, SHBG, and albumin concentrations. Equilibrium dialysis is the gold-standard direct measurement but is costly and not widely available clinically. For most men undergoing TRT evaluation, the calculated free testosterone from a panel that includes total testosterone, SHBG, and albumin is sufficient to guide clinical decision-making [5].

Albumin-bound testosterone occupies a middle ground. Its binding to albumin is roughly 1,000-fold weaker than SHBG binding, so some albumin-bound testosterone can dissociate at capillary beds and enter tissue. That fraction, combined with free testosterone, constitutes bioavailable testosterone. Reference ranges for bioavailable testosterone in adult men run approximately 130 to 280 ng/dL by most laboratory standards, though these vary by assay method.

How the HPG Axis Controls Testosterone Production and How SHBG Feeds Back into It

The hypothalamic-pituitary-gonadal (HPG) axis operates as a closed-loop feedback system. The hypothalamus releases gonadotropin-releasing hormone (GnRH) in pulses, typically every 90 to 120 minutes. GnRH reaches the anterior pituitary, which responds by secreting luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH stimulates Leydig cells in the testes to produce testosterone [6].

Rising testosterone feeds back to suppress both the hypothalamus and the pituitary, dampening GnRH and LH secretion. Free estradiol, produced via aromatization of testosterone, provides an even more potent suppressive signal at the pituitary [7]. SHBG enters this loop in a subtle but clinically significant way: because the pituitary senses total circulating androgens (including bound fractions), changes in SHBG can alter the perceived androgen signal and shift GnRH pulse frequency.

Men who take exogenous testosterone completely suppress the HPG axis. LH drops to near zero within days of starting TRT, Leydig cell stimulation ceases, and intratesticular testosterone falls from roughly 70 ng/mL to below 2 ng/mL [8]. That collapse of intratesticular testosterone is why exogenous TRT without co-administered human chorionic gonadotropin (hCG) leads to testicular atrophy and azoospermia in most men within three to six months. The FDA-approved prescribing information for testosterone cypionate notes this suppression explicitly as a risk requiring monitoring [9].

Clomiphene citrate (clomiphene), used off-label in men who want to preserve fertility while raising testosterone, blocks estrogen receptors at the hypothalamus and pituitary, removing the negative feedback signal. LH rises, stimulating endogenous testosterone production without the HPG axis suppression that accompanies exogenous androgens [10].

The Aromatization Pathway: How Testosterone Becomes Estradiol and Why That Raises SHBG

Aromatase (CYP19A1) converts testosterone to 17-beta-estradiol. In men, roughly 80% of circulating estradiol comes from peripheral aromatization in adipose tissue, liver, brain, and bone rather than from direct testicular secretion [11].

Estradiol is a potent stimulus for hepatic SHBG synthesis. Men with obesity carry more adipose aromatase, produce more estradiol, and tend to have higher SHBG, which in turn reduces free testosterone. That creates a self-reinforcing cycle: excess adipose tissue increases aromatization, estradiol rises, SHBG rises, free testosterone falls, and lower free testosterone reduces the metabolic signals that would otherwise restrain fat accumulation [12].

On TRT, supraphysiologic testosterone levels accelerate aromatization. Estradiol can climb into ranges that cause gynecomastia (typically above 40 to 60 pg/mL in symptomatic men), fluid retention, and mood instability. Anastrozole (1 mg orally, taken two to three times per week) and exemestane are the aromatase inhibitors most commonly used in TRT protocols to manage this, though neither is FDA-approved specifically for that indication [13]. Dosing is guided by serial estradiol measurement. Over-suppression of estradiol below approximately 20 pg/mL carries its own risks, including bone loss, joint pain, and worsening lipid profiles, since estradiol is essential for male bone mineral density [14].

What Drives SHBG Up or Down? Modifiable and Non-Modifiable Factors

SHBG is not fixed. Several factors shift it substantially.

Factors that raise SHBG:

Hyperthyroidism can double or triple SHBG concentrations [1]. Liver cirrhosis paradoxically raises SHBG in early stages by altering hepatic synthesis. Oral estrogens (such as those in some hormonal contraceptives or oral estradiol HRT formulations) pass through the portal circulation and strongly upregulate SHBG gene expression, unlike transdermal estradiol, which largely bypasses first-pass hepatic exposure. Aging raises SHBG through mechanisms that include increased hepatic sensitivity to IGF-1 decline. Anticonvulsants such as phenytoin and carbamazepine also raise SHBG [15].

Factors that lower SHBG:

Insulin resistance and type 2 diabetes suppress SHBG. The Framingham Heart Study offspring cohort (N=1,754) found that each standard deviation increase in fasting insulin was associated with a 10% lower SHBG concentration [16]. Obesity, through hyperinsulinemia, drives the same suppression. Exogenous androgens, including testosterone itself, lower SHBG, which is one reason total testosterone can appear lower than expected on certain TRT formulations. Hypothyroidism lowers SHBG. Glucocorticoids suppress SHBG modestly. Danazol, a synthetic androgen, substantially lowers SHBG and has been used deliberately in this way in some clinical protocols.

Diet: A randomized crossover study published in the Journal of Steroid Biochemistry and Molecular Biology found that a low-fat, high-fiber diet reduced SHBG by 12 to 15% relative to a high-fat diet in healthy men, likely through insulin pathway modulation [17]. Zinc deficiency may reduce SHBG indirectly by altering LH signaling, though direct evidence in humans remains limited.

How to Interpret Your SHBG Lab Result

Most U.S. laboratories report SHBG in nmol/L with a reference range of 10 to 57 nmol/L for adult men, though some labs use 16.5 to 55.9 nmol/L. The number alone tells you little without the companion total testosterone and albumin values needed to calculate free and bioavailable testosterone.

High SHBG with normal total testosterone: Free testosterone is likely low. Symptoms of hypogonadism (fatigue, low libido, erectile dysfunction, reduced lean mass, cognitive fog) with a total testosterone in the normal range (typically 300 to 900 ng/dL per most guidelines) should prompt calculation of free testosterone. If free testosterone falls below approximately 65 pg/mL by equilibrium dialysis or the equivalent by Vermeulen calculation, the Endocrine Society considers the result clinically significant in the context of symptoms [4].

Low SHBG with normal total testosterone: Free testosterone is likely high. Isolated low SHBG in the context of obesity or insulin resistance does not necessarily indicate a problem, but it should prompt evaluation for metabolic syndrome, non-alcoholic fatty liver disease, and hypothyroidism.

Low total testosterone with low SHBG: This pattern is common in obese men with insulin resistance. Total testosterone may appear borderline low (for example, 280 to 350 ng/dL), but free testosterone may actually fall within an adequate range because SHBG is not consuming a large fraction. Clinical decision-making must account for free testosterone, not total T alone.

Low total testosterone with high SHBG: This is the most unambiguous pattern for clinically significant hypogonadism. Both total and free testosterone are reduced. This pattern often appears in aging men, men with hyperthyroidism, or men on medications that raise SHBG.

The HealthRX SHBG Interpretation Framework summarizes the four-quadrant pattern above (high/low SHBG crossed with high/low total testosterone) and maps each to a likely clinical diagnosis and next step, from watchful waiting in low-SHBG/normal-T obesity to full TRT evaluation in high-SHBG/low-T aging hypogonadism.

Calculating and Measuring Bioavailable Testosterone

Bioavailable testosterone equals free testosterone plus albumin-bound testosterone. The simplest clinical approach is to use the Vermeulen calculator, which requires three inputs: total testosterone (ng/dL), SHBG (nmol/L), and albumin (g/dL, typically assumed at 4.3 g/dL if not measured). The formula was validated in a 1999 paper by Vermeulen et al. in the Journal of Clinical Endocrinology and Metabolism against equilibrium dialysis as the reference standard, showing a correlation coefficient of 0.975 [5].

Equilibrium dialysis directly separates free testosterone from bound fractions by dialyzing serum across a semi-permeable membrane. It is the most accurate method but adds cost and is not available at all commercial labs. Quest Diagnostics and LabCorp both offer it as a send-out test.

For men on TRT, monitoring free testosterone is especially informative. Testosterone cypionate injected intramuscularly creates peak serum concentrations 24 to 72 hours post-injection, with a half-life of approximately 8 days [9]. SHBG fluctuates across that cycle as estradiol rises and falls with the testosterone peak. Drawing labs at trough (just before the next injection) gives the most consistent and conservative estimate of free testosterone during treatment.

SHBG and Fertility: The Intratesticular Testosterone Problem

Men considering TRT who also want to preserve fertility face a specific SHBG-related complication. Exogenous testosterone suppresses LH, collapses intratesticular testosterone, and blocks spermatogenesis even when serum testosterone looks excellent [8]. High circulating SHBG during a TRT cycle does not protect fertility because the intratesticular microenvironment requires locally produced testosterone, not circulating bound testosterone, to support Sertoli cell function and sperm maturation.

Co-administration of hCG at 500 to 1 to 500 IU subcutaneously two to three times per week partially maintains intratesticular testosterone and preserves testicular volume in most men on TRT. A prospective study published in Fertility and Sterility (N=26) found that hCG co-therapy maintained intratesticular testosterone at concentrations comparable to eugonadal controls, whereas men on testosterone alone showed a 94% reduction in intratesticular testosterone [18].

Men who prefer to avoid exogenous androgens entirely may be candidates for selective estrogen receptor modulators such as clomiphene or enclomiphene, which raise endogenous LH and testosterone while leaving the HPG axis intact, preserving sperm production and avoiding the SHBG-suppressive effects of exogenous testosterone [10].

SHBG in the Context of TRT Monitoring: What to Test and When

A complete TRT monitoring panel should include total testosterone, free testosterone (calculated or by equilibrium dialysis), SHBG, albumin, estradiol (sensitive LC-MS/MS assay preferred over immunoassay in men), LH (to confirm HPG suppression), hematocrit, PSA, and a basic metabolic panel to catch liver changes that could alter SHBG [4].

The Endocrine Society's 2018 guideline recommends checking testosterone three to six months after starting therapy, then annually once stable [4]. SHBG should be rechecked any time a dosage change is made, a new medication affecting SHBG is added, or symptoms change despite previously adequate labs. A rise in SHBG during TRT, for example, from a newly prescribed anticonvulsant or oral estrogen formulation in a partner using shared medications, can drive free testosterone below therapeutic range without any change in total testosterone dose.

Hematocrit must be monitored because testosterone stimulates erythropoiesis. The Endocrine Society recommends withholding or reducing TRT if hematocrit exceeds 54% due to increased thrombotic risk [4]. This threshold is not directly related to SHBG but appears on the same monitoring schedule and is a safety parameter the prescribing clinician tracks alongside hormone fractions.

Practical Steps for Men With High SHBG

Men found to have elevated SHBG with low free testosterone have several options depending on their clinical picture.

Addressing modifiable causes comes first. Treating hypothyroidism (levothyroxine titrated to a TSH target of 0.5 to 2.5 mIU/L in symptomatic patients) can substantially reduce SHBG within weeks of achieving euthyroid status [1]. Improving insulin sensitivity through weight loss reduces SHBG via the insulin-suppression pathway described earlier. Removing or replacing medications that raise SHBG, such as switching from oral to transdermal estrogen in appropriate patients, may reduce SHBG meaningfully [19].

If SHBG remains high despite addressing modifiable factors, and free testosterone is consistently below the symptomatic threshold, testosterone therapy is a reasonable next step. For men with very high SHBG, injectable testosterone cypionate or enanthate tends to produce larger swings in free testosterone than transdermal gels, because peak serum concentrations are higher. Testosterone undecanoate (Aveed, 750 mg IM every 10 weeks after loading doses) provides steadier levels and may produce more consistent free testosterone exposure in high-SHBG men, though clinical head-to-head data comparing formulations specifically in high-SHBG populations remain sparse [9].

Danazol at 50 to 200 mg/day has been used experimentally to lower SHBG in men with refractory high SHBG on TRT, but its androgenic and hepatotoxic side effects limit routine use. Stanozolol is sometimes cited in the same context, but neither drug carries FDA approval for SHBG management, and prescribing them in this context is off-label with limited safety data.

Monitoring free testosterone, not just total testosterone, is the measure that determines whether the intervention is working. A total testosterone of 800 ng/dL with SHBG of 80 nmol/L may still leave a man with a free testosterone below 80 pg/mL, squarely in the symptomatic range for many men.